Kim H, Jeong J, Huh W
Cell Commun Signal. 2025; 23(1):111.
PMID: 40012038
PMC: 11863771.
DOI: 10.1186/s12964-025-02099-x.
Akiba H, Ise T, Satoh R, Abe Y, Tsumoto K, Ohno H
Antib Ther. 2025; 8(1):56-67.
PMID: 39958564
PMC: 11826918.
DOI: 10.1093/abt/tbaf002.
Sun Y, Ma L, Zhang X, Wang Z
Onco Targets Ther. 2024; 17:1095-1115.
PMID: 39583247
PMC: 11585992.
DOI: 10.2147/OTT.S487870.
Sungwan P, Panaampon J, Kariya R, Kamio S, Nakagawa R, Hirozane T
Hum Cell. 2024; 37(4):1215-1225.
PMID: 38755432
DOI: 10.1007/s13577-024-01077-8.
Printsev I, Alalli E, Bilsborough J
Curr Issues Mol Biol. 2024; 46(3):2741-2756.
PMID: 38534788
PMC: 10969620.
DOI: 10.3390/cimb46030172.
ALK fusions in the pan-cancer setting: another tumor-agnostic target?.
Shreenivas A, Janku F, Gouda M, Chen H, George B, Kato S
NPJ Precis Oncol. 2023; 7(1):101.
PMID: 37773318
PMC: 10542332.
DOI: 10.1038/s41698-023-00449-x.
Targeting EML4-ALK gene fusion variant 3 in thyroid cancer.
Aydemirli M, van Eendenburg J, van Wezel T, Oosting J, Corver W, Kapiteijn E
Endocr Relat Cancer. 2021; 28(6):377-389.
PMID: 33878728
PMC: 8183637.
DOI: 10.1530/ERC-20-0436.
EBP2, a novel NPM-ALK-interacting protein in the nucleolus, contributes to the proliferation of ALCL cells by regulating tumor suppressor p53.
Uchihara Y, Tago K, Tamura H, Funakoshi-Tago M
Mol Oncol. 2020; 15(1):167-194.
PMID: 33040459
PMC: 7782078.
DOI: 10.1002/1878-0261.12822.
CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma.
Fordham A, Xie J, Gifford A, Wadham C, Morgan L, Mould E
Br J Cancer. 2020; 123(7):1101-1113.
PMID: 32684628
PMC: 7524717.
DOI: 10.1038/s41416-020-0996-2.
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models.
Ng S, Yoshida N, Christie A, Ghandi M, Dharia N, Dempster J
Nat Commun. 2018; 9(1):2024.
PMID: 29789628
PMC: 5964252.
DOI: 10.1038/s41467-018-04356-9.
Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond.
Prokoph N, Larose H, Lim M, Burke G, Turner S
Cancers (Basel). 2018; 10(4).
PMID: 29601554
PMC: 5923354.
DOI: 10.3390/cancers10040099.
Small cell variant of anaplastic large cell lymphoma with leukemic presentation: a diagnostic challenge.
Barrese T, Sagramoso C, Bacci F, Sabattini E
Rev Bras Hematol Hemoter. 2017; 39(3):269-273.
PMID: 28830608
PMC: 5568588.
DOI: 10.1016/j.bjhh.2017.05.009.
Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein-Barr virus-positive patients with chronic lymphocytic leukemia.
Diamantopoulos P, Sofotasiou M, Georgoussi Z, Giannakopoulou N, Papadopoulou V, Galanopoulos A
Cancer Med. 2016; 5(9):2240-8.
PMID: 27367207
PMC: 5055175.
DOI: 10.1002/cam4.804.
Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency.
Salem B, Miner S, Hensel N, Battiwalla M, Keyvanfar K, Stroncek D
Cytotherapy. 2015; 17(12):1675-86.
PMID: 26422657
PMC: 4655179.
DOI: 10.1016/j.jcyt.2015.08.008.
Quantitative detection of rare interphase chromosome breaks and translocations by high-throughput imaging.
Burman B, Misteli T, Pegoraro G
Genome Biol. 2015; 16:146.
PMID: 26313373
PMC: 4531802.
DOI: 10.1186/s13059-015-0718-x.
Histone modifications predispose genome regions to breakage and translocation.
Burman B, Zhang Z, Pegoraro G, Lieb J, Misteli T
Genes Dev. 2015; 29(13):1393-402.
PMID: 26104467
PMC: 4511214.
DOI: 10.1101/gad.262170.115.
Anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma with involvement of the urinary bladder: a case report and review of literature.
Liang X, Wang Y, Zhang J, Cheng H, Wang J, Dang Y
Onco Targets Ther. 2015; 8:1143-7.
PMID: 26056479
PMC: 4446009.
DOI: 10.2147/OTT.S77297.
Peptides derived from the dependence receptor ALK are proapoptotic for ALK-positive tumors.
Aubry A, Galiacy S, Ceccato L, Marchand C, Tricoire C, Lopez F
Cell Death Dis. 2015; 6:e1736.
PMID: 25950466
PMC: 4669685.
DOI: 10.1038/cddis.2015.102.
Vorinostat downregulates CD30 and decreases brentuximab vedotin efficacy in human lymphocytes.
Hasanali Z, Epner E, Feith D, Loughran Jr T, Sample C
Mol Cancer Ther. 2014; 13(12):2784-92.
PMID: 25319394
PMC: 4258453.
DOI: 10.1158/1535-7163.MCT-14-0593.
Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity.
Giefing M, Winoto-Morbach S, Sosna J, Doring C, Klapper W, Kuppers R
PLoS One. 2013; 8(12):e84928.
PMID: 24376854
PMC: 3871653.
DOI: 10.1371/journal.pone.0084928.